 |
市场调查报告书
商品编码
1149871
儿科临床试验市场：按临床试验阶段、研究设计、疾病状况、地区 - 规模、份额、展望、机会分析，2022-2030 年Pediatric Clinical Trials Market, by Clinical Trial Phase, by Study Design, by Medical Condition, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 |
||||||
价格
简介目录
儿科临床试验在现代医疗保健中发挥着重要作用，作为针对影响儿科人群的各种适应症将新药推向市场的单一标准。儿科临床试验对于开发适合年龄的、经过经验验证的治疗和干预措施以及确定和改善现有的最佳医疗服务至关重要。
临床开发中有许多产品管线可以满足儿科患者未满足的医疗需求。儿科临床试验可以帮助确定儿童药物和疫苗的理想剂量，还可以专注于创造易于吞嚥的液体製剂。儿科临床试验有助于开发对儿童安全有效的药物和免疫接种。儿科临床试验可以帮助开发适合儿童剂量的药物和疫苗，并可以专注于开发更易于吞嚥的液体製剂。儿童参与临床试验有助于为儿童开发安全有效的药物和疫苗。
市场动态
对预防麻疹、腮腺炎、脊髓灰质炎、肺结核、风疹、流感、百日咳、水痘、疟疾和链球菌性咽喉炎等各种传染病的新疫苗和其他生物製剂的需求不断增加，正在推动市场。预计将带动的增长例如，根据国际糖尿病联合会 (IDF) 糖尿病地图集 2020，2019 年全球将有约 4.63 亿人患有糖尿病。其中，100 万（20 岁以下的儿童和青少年）患有 1 型糖尿病。
这项研究的主要特点
- 本报告对全球儿科临床试验市场进行了深入分析，阐明了以 2021 年为基准年的预测期（2022-2030 年）内市场规模和復合年增长率 (CAGR%) 的增长。
- 解释了不同细分市场的潜在创收机会，并描述了针对该市场的有吸引力的投资建议矩阵。
- 它还提供了有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
- 根据公司亮点、产品组合、主要亮点、财务业绩和战略等参数，对全球儿科临床试验市场的主要参与者进行概况分析。
- 本研究涵盖的主要公司包括 Syneos Health Inc.、IQVIA Holdings, Inc.、Charles River Laboratories International Inc.、Covance Inc.、ICON plc、Pharmaceutical Product Development, LLC、Genentech (F. Hoffmann-La Roche AG)、Pfizer, Inc.、Bristol-Myers Squibb、GlaxoSmithKline plc.、Sanofi S.A.、Novartis AG、强生、默克公司、Takeda Pharmaceutical Company Limited 和 Vertex Pharmaceuticals Inc.。
- 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
- 《全球儿科临床试验市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
- 利益相关者可以通过用于分析全球儿科临床试验市场的各种战略矩阵来促进决策制定。
内容
第 1 章目的和先决条件
- 调查目的
- 先决条件
- 缩写说明
第二章市场展望
- 报告内容
- 市场定义和范围
- 执行摘要
- 市场概况：按临床试验阶段
- 研究设计的市场概况
- 市场概况：按医疗条件
- 市场概况：按地区
- 连贯机会图 (COM)
第3章市场动态、规律及趋势分析
- 市场动态
- 司机
- 约束因素
- 市场机会
- 影响分析
- 市场趋势
- 近期趋势
- 收购和合作场景
- 技术概览
- 监管情景
- 管道分析
- 害虫分析
第 4 章全球儿科临床试验市场：冠状病毒 (COVID-19) 大流行的影响
- 总体影响
- 对供需的影响
- COVID-19 对市场的影响
第 5 章全球儿科临床试验市场：按临床试验阶段，2017-2030
- 临床前研究
- 第一阶段
- 第二阶段
- 第三阶段
第 6 章全球儿科临床试验市场：按研究设计，2017-2030
- 治疗研究
- 观察性研究
第 7 章全球儿科临床试验市场：按条件，2017-2030
- 神经精神系统疾病
- 感染
- 孕产妇和围产期疾病
- 呼吸系统疾病
- 心血管疾病
- 癌症
- 消化系统疾病
- 其他
第 8 章全球儿科临床试验市场：按地区划分，2017-2030
- 北美
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲地区
- 欧洲
- 英国
- 德国
- 意大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲地区
- 亚太地区
- 中国
- 印度
- 日本
- 东盟
- 澳大利亚
- 韩国
- 其他亚太地区
- 中东
- 海湾合作委员会
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中非
- 南非
第9章竞争格局
- Syneos Health Inc
- IQVIA Holdings, Inc.
- Charles River Laboratories International Inc
- Covance Inc
- ICON plc
- Pharmaceutical Product Development, LLC
- Genentech（F. Hoffmann-La Roche AG
- Pfizer, Inc
- Bristol-Myers Squibb
- GlaxoSmithKline plc
- Sanofi S.A
- Novartis AG
- Johnson & Johnson
- Merck & Co., Inc
- Takeda Pharmaceutical Company Limited
- Vertex Pharmaceuticals Inc.
第 10 章
- 调查方法
- 关于出版商
简介目录
Product Code: CMI397
Pediatric clinical trials play a major role in modern healthcare, as pediatric clinical trials are the only criteria to launch new drugs in market for various indications that affect pediatric population. Clinical trials in children are essential to develop age-specific, empirically-verified therapies and interventions to determine and improve the best medical treatment available.
There is significant product pipeline under clinical stage of development due to unmet medical needs for pediatric patient population. A pediatric clinical trial could assist in determining the ideal dosage of a medication or vaccine for a child, or it could concentrate on creating an easier-to-swallow liquid formulation. Clinical trials involving children aid in the development of child-safe and -effective medications and vaccinations. A pediatric clinical trial could help develop the correct dose of a medicine or vaccine for a child, or it could focus on development of a liquid formulation that is easier to swallow. Participation from children in clinical trials helps develop medicines and vaccines that are safe and effective for children.
Market Dynamics
Increasing demand for new vaccines and other biologic products to prevent various infectious diseases such as measles, mumps, polio, tuberculosis, rubella, influenza, whooping cough, chickenpox, malaria, and streptococcal pharyngitis is expected to drive the market growth. For instance, according to the International Diabetes Federation's (IDF) Diabetes Atlas 2020, around 463 million patients were suffering from diabetes worldwide in 2019. Of this, one million people (children and adolescents below 20 years of age) were suffering from type 1 diabetes.
Key features of the study:
- This report provides in-depth analysis of the global pediatric clinical trials market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pediatric clinical trials market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Syneos Health Inc., IQVIA Holdings, Inc., Charles River Laboratories International Inc., Covance Inc., ICON plc, Pharmaceutical Product Development, LLC, Genentech (F. Hoffmann-La Roche AG), Pfizer, Inc., Bristol - Myers Squibb, GlaxoSmithKline plc., Sanofi S.A., Novartis AG, Johnson & Johnson, Merck & Co., Inc., Takeda Pharmaceutical Company Limited, and Vertex Pharmaceuticals Inc
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global pediatric clinical trials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric clinical trials market
Detailed Segmentation:
- Global Pediatric Clinical Trials Market, By Clinical Trial Phase :
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Global Pediatric Clinical Trials Market, By Study Design:
- Treatment Studies
- Observational Studies
- Global Pediatric Clinical Trials Market, By Medical Condition:
- Neuropsychiatric Conditions
- Infectious Diseases,
- Maternal and Perinatal Conditions,
- Respiratory Diseases,
- Cardiovascular Diseases
- Cancer
- Digestive
- Others
- Global Pediatric Clinical Trials Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- Syneos Health Inc
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- IQVIA Holdings, Inc.,
- Charles River Laboratories International Inc.
- Covance Inc.,
- ICON plc,
- Pharmaceutical Product Development, LLC,
- Genentech (F. Hoffmann-La Roche AG),
- Pfizer, Inc.,
- Bristol - Myers Squibb,
- GlaxoSmithKline plc.,
- Sanofi S.A.,
- Novartis AG,
- Johnson & Johnson,
- Merck & Co., Inc.,
- Takeda Pharmaceutical Company Limited,
- Vertex Pharmaceuticals Inc
- Syneos Health Inc
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Clinical Trial Phase
- Market Snapshot, By Study Design
- Market Snapshot, By Medical Condition
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Pipeline Analysis
- PEST Analysis
4. Global Pediatric Clinical Trials Market- Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact
- Impact on Supply and Demand
- COVID-19 Impact on the market
5. Global Pediatric Clinical Trials Market, By Clinical Trial Phase , 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Pre-clinical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Phase I
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Phase II
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Phase III
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
6. Global Pediatric Clinical Trials Market, By Study Design , 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Treatment Studies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Observational
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
7. Global Pediatric Clinical Trials Market, By Medical Condition, 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Neuropsychiatric Conditions,
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Infectious Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Maternal and Perinatal Conditions
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Respiratory Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Cardiovascular Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Digestive Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
8. Global Pediatric Clinical Trials Market, By Region, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Study Design, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Medical Condition, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Study Design, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Medical Condition, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Study Design, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Medical Condition, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Study Design, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Medical Condition, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Study Design, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Medical Condition, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Study Design, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Medical Condition, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Syneos Health Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- IQVIA Holdings, Inc.
- Charles River Laboratories International Inc
- Covance Inc
- ICON plc
- Pharmaceutical Product Development, LLC
- Genentech (F. Hoffmann-La Roche AG
- Pfizer, Inc
- Bristol - Myers Squibb
- GlaxoSmithKline plc
- Sanofi S.A
- Novartis AG
- Johnson & Johnson
- Merck & Co., Inc
- Takeda Pharmaceutical Company Limited
- Vertex Pharmaceuticals Inc.
10. Section
- Research Methodology
- About Us
